Islamabad, 3rd April 2023. The Commission on Science and Technology for Sustainable Development in the South (COMSATS), an intergovernmental organization of 27 Member States, having mandate to play leadership role for ST&I led sustainable development, signed a Letter of Intent (LoI) with the Syndesis Health Inc. The LOI would enable reaching a Memorandum of Understanding to offer ‘turnkey’ solution to COMSATS’ Member States and pave way for establishing, financing and managing “National Genomic Sequencing Programs” for the interested Members.

Syndesis Health Inc. is a company incorporated in Delaware, USA, with its business office at New York. It accelerates research and innovation for healthcare, life sciences, and biotechnology companies. On behalf of COMSATS, the LoI was signed by its Executive Director, Amb. Dr. Mohammad Nafees Zakaria, while for Syndesis Health Inc, its Co-Founder & Director, Mr. Kamil Mehmood signed the Letter.

This collaboration will enable healthcare organizations of the Member State to provide citizens with personalized medical recommendations based on their unique genetic makeup, provide better healthcare to the citizens, support development of new drugs and treatments, and devise guidelines and regulate pharmaceutical products manufacturing, within the country or in case of importation, specific to its citizens’ requirement.

Some of the technical activities of the program will entail upgradation of existing Labs, promote scientific researches, identification of ‘genetic markers’ for certain diseases, help structure and combine ‘genomic sequencing with the existing ‘health records’ with hospitals across the country, and provide AI powered software and analytics.